ASPIRA & Tree of Life

Manufactured by Tree of Life Pharma Ltd. Innovative pharmaceutical and health products since 2001 Developed and produced in Lod, Israel
Innovation in Oral Care

ASPIRA Breath Tablets

Patented Slow-Release Freshness That Works for Hours

ASPIRA is an innovative oral mucoadhesive tablet manufactured by Tree of Life Pharma Ltd. The discreet tablet adheres inside the mouth and gradually releases its plant-based formula, helping maintain fresh breath for up to eight hours.

Learn More and Purchase ASPIRA How ASPIRA Works
ASPIRA Breath Tablets manufactured by Tree of Life Pharma
The Manufacturer

About Tree of Life Pharma Ltd.

Founded 2001
Headquarters Lod, Israel
Core Technology Oral mucoadhesive delivery
Markets Served Americas, Europe, Middle East, Africa, Asia, Oceania

Tree of Life Pharma Ltd. is an Israeli pharmaceutical and health products company founded in 2001 and based in Lod, Israel. Over more than two decades the company has built a portfolio of uniquely formulated health products, many of them protected by international patents, and develops its formulations in house rather than licensing them in.

The company's work centres on delivering active ingredients where conventional formats struggle: the mouth, the throat and the ear. That focus produced the oral mucoadhesive technology behind ASPIRA Breath Tablets, alongside a wider range covering oral care, ear and throat care, pediatric and first-aid products, dermatology, eye care and supplements.

Tree of Life Pharma products reach customers in Israel and internationally, across North and South America, the European Union and wider Europe, the Middle East, Africa, East, South and Southeast Asia, and Oceania.

ASPIRA Breath Tablets are sold to consumers through the brand's own store. Product details, usage guidance and ordering are available on the ASPIRA official website.

In-House Development

Formulations are developed by the company itself, from initial concept through to the finished product.

Mucoadhesive Delivery Platform

A core company technology for the oral cavity, applied across its oral-care and ENT range. ASPIRA is built on it.

Patent-Protected Formulations

Many of the company's products are covered by international patents, including the ASPIRA delivery system.

Registrations and Listings

The company maintains the product registrations and facility listings required in the markets it supplies.

Innovation and Credibility

The Technology Behind ASPIRA

ASPIRA applies a patented oral mucoadhesive delivery system. Rather than dissolving within seconds like a conventional mint, the tablet attaches to the oral mucosa and releases its formula gradually. Mucoadhesive formulation for the oral cavity is a core Tree of Life Pharma technology, applied across the company's oral-care and ENT range for more than two decades; ASPIRA is the fresh-breath application of that platform.

In the United States, ASPIRA is a cosmetic oral-care product. It is listed with the U.S. Food and Drug Administration as a cosmetic product under MoCRA, and it is produced at Tree of Life Pharma's own facility in Lod, Israel, which is registered with the FDA as a cosmetic manufacturing facility under the same regulation. The delivery technology behind the product is covered by U.S. Patent No. 9,480,641 B2 and European Patent No. EP 2066304B1.

For full product information, usage guidance, and purchasing options, visit the official ASPIRA website.

About MoCRA registration and listing Cosmetic facility registration and product listing are record-keeping requirements introduced by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Details of what registration and listing involve are published by the FDA under Registration & Listing of Cosmetic Product Facilities and Products. As the FDA states, registration and listing are not an approval programme and do not constitute an FDA endorsement of a product.
Manufacturer Tree of Life Pharma Ltd.Pharmaceutical and health products since 2001
Manufacturing Site Lod, IsraelRegistered with the U.S. Food and Drug Administration as a cosmetic manufacturing facility under MoCRA
Product Type Patented oral mucoadhesive tabletSlow-release fresh-breath tablet for oral care
Regulatory Status (US) Cosmetic oral-care productListed with the U.S. Food and Drug Administration as a cosmetic product under MoCRA. What registration and listing means
U.S. Patent No. 9,480,641 B2
European Patent No. EP 2066304B1
Formula Plant-based, sugar-free, alcohol-freeEchinacea, lavender, mastic gum and salvia
Where to Buy ASPIRA official websiteaspira-breath.com
Product Highlights

A different kind of fresh-breath tablet

  • Up to 8 Hours of Freshness

    A single tablet is designed to help maintain fresh breath for up to eight hours.

  • Patented Slow-Release Technology

    A mucoadhesive delivery system protected by granted United States and European patents.

  • Plant-Based Formula

    Built around four selected botanicals: echinacea, lavender, mastic gum and salvia.

  • Sugar-Free and Alcohol-Free

    Formulated without sugar and without alcohol for comfortable use through the day.

  • Discreet Oral-Adhesive Tablet

    The small tablet adheres inside the mouth and stays out of sight while it works.

Three Simple Steps

How ASPIRA Works

ASPIRA works discreetly in the background, allowing users to speak, drink, and continue their normal daily activities.

  1. Place

    Place one tablet on the upper palate or inside the cheek using a clean, dry finger.

  2. Adhere

    Hold it gently in place for 5-10 seconds so it can adhere.

  3. Slow Release

    The tablet gradually dissolves and releases its botanical formula over time.

Good to know: the tablet itself generally dissolves over approximately one to two hours. The fresh-breath effect is designed to continue for up to eight hours after use.

Full usage instructions and product details are published on the official ASPIRA product page.

The Formula

Four Botanicals, One Slow-Release System

ASPIRA combines four carefully selected botanical ingredients within a patented mucoadhesive delivery system designed for gradual release and long-lasting fresh-breath support.

  • EchinaceaEchinacea purpurea

    A flowering plant of the daisy family, used here as a botanical extract.

  • LavenderLavandula angustifolia

    An aromatic flowering herb, long associated with Mediterranean botanical traditions.

  • Mastic GumPistacia lentiscus

    The natural resin of the Mediterranean mastic tree, harvested from its bark.

  • Salvia (Sage)Salvia officinalis

    The aromatic leaf of the common sage plant, a classic culinary and garden herb.

ASPIRA Official Website

Discover a Different Approach to Lasting Fresh Breath

Learn more about ASPIRA's patented slow-release technology, botanical formula, usage instructions, and available purchasing options.

Learn More and Purchase ASPIRA

You will be directed to the official ASPIRA website.

ASPIRA Breath Tablets are manufactured by Tree of Life Pharma Ltd., Lod, Israel, and are a cosmetic oral-care product intended to help maintain fresh breath. Listed with the U.S. Food and Drug Administration as a cosmetic product under MoCRA; registration and listing are not an FDA approval or endorsement. This page is informational; purchasing is handled on the ASPIRA official website.